BRCA2 and ductal breast carcinoma in situ: A BRCA1 or BRCA2 mutation was observed in 5 of 154 (3.25%) women diagnosed with DCIS before the age of 50, compared to 10 of 410 (2.44%) women with DCIS diagnosed above the age of 49 (p = 0.6).